Analyst Ratings for Aclaris Therapeutis (ACRS)
ACRS Rating Summary
ACRS Price Target Summary
- Highest: $16.00 (H.C. Wainwright)
- Lowest: $4.00 (Stifel)
- Average: $10.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.00 (+66.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$10.00 (+66.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Canaccord | Edward Nash | New Coverage | Buy (N/A) |
10.00 (N/A) |
6.05 (6.02) |
-0.5% | Details |
| 5/4/2026 | Guggenheim | Seamus Fernandez | New Coverage | Buy (N/A) |
12.00 (N/A) |
4.41 (6.02) |
36.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
